COMMUNIQUÉS West-GlobeNewswire

AccuStem Sciences to Offer its MSC Blood Test to Lung Cancer Screening Programs in the United States

04/04/2025 - 13:00

LONDON and PHOENIX, April 04, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, announces plans [...]

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference

04/04/2025 - 13:00

BELTSVILLE, Md., April 04, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to [...]

American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results

04/04/2025 - 13:00

Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), [...]

Axsome Therapeutics Presents Positive Pivotal Phase 3 Results of the ACCORD-2 Trial of AXS-05 in Alzheimer’s Disease Agitation and the SYMPHONY Trial of AXS-12 in Narcolepsy at the 2025 American Academy of Neurology (AAN) Annual Meeting

04/04/2025 - 13:00

Late-breaking oral presentation of results from the positive pivotal ACCORD-2 Phase 3 trial of AXS-05 in Alzheimer’s disease agitation Presentation featuring network meta-analysis of SYMBRAVO ® versus oral CGRPs NEW [...]

Verano to Report First Quarter 2025 Financial Results on May 8, 2025

04/04/2025 - 12:00

CHICAGO, April 04, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial [...]

New LabTAG Add-On Streamlines Laboratory Labeling with Dymo® LabelWriter™ 5-Series and eLabNext Integration

04/04/2025 - 11:48

BOSTON, April 04, 2025 (GLOBE NEWSWIRE) -- GA International , a global leader in laboratory identification solutions, under its LabTAG brand, announced today that its DYMO® LabelWriter™ 5-Series Printing Kits are now [...]

Dogecoin Cash, Inc. Subsidiary PrestoDoctor Launches April Promotion Offering 42.0% Off Medical Cannabis Evaluations

04/04/2025 - 10:20

MESQUITE, NV, April 04, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV — Dogecoin Cash, Inc. (OTCIQ: CBDS), is pleased to announce that its subsidiary, PrestoDoctor ( www.prestodoctor.com ), is rolling out a limited-time April [...]

Happy Go Leafy Tops Washington City Paper’s 2025 List of Best Kratom Brands

04/04/2025 - 10:00

Happy Go Leafy tops Washington City Paper’s 2025 list of best Kratom brands, recognized for premium quality and customer satisfaction. Charlotte, NC , April 04, 2025 (GLOBE NEWSWIRE) -- Happy Go Leafy has proudly [...]

IBA to share long-term growth strategy at upcoming 2025 Capital Markets Day

04/04/2025 - 07:00

Louvain-la-Neuve, Belgium, 04 April, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will be hosting a Capital Markets Day (CMD) this coming Monday 7 April from [...]

IBA présente sa stratégie de croissance à long terme lors de son Capital Markets Day 2025

04/04/2025 - 07:00

Louvain-la-Neuve, Belgique, le 4 avril 2025 - IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules, organise un Capital Markets Day (CMD-journée investisseurs) ce [...]

Zelluna ASA [ZLNA]: Notice of Annual General Meeting on April 29, 2025

04/04/2025 - 07:00

Oslo, April 04, 2025, the Board of Directors hereby calls for the Annual General Meeting of Zelluna ASA at 14:00 CET on April 29, 2025. The General Meeting will be held electronically. For participation, please log in [...]

Mesoblast Allogeneic Cell Therapy Products Are Designated ‘U.S. Country of Origin’ and Not Subject to U.S. Tariffs

04/04/2025 - 00:58

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on the status of its products in relation [...]

Annexon Highlights Leadership in Advancing Clinical Research and Education for Guillain-Barré Syndrome (GBS) at American Academy of Neurology (AAN) 2025 Annual Meeting

04/04/2025 - 00:18

Oral Plenary Presentation on Tuesday, April 8 Features Phase 3 Data for ANX005, the First Potential Targeted Therapy for GBS, Showing Rapid and Durable Benefit Across Clinical Measures and Time Points Educational [...]

Anne Whitaker Appointed as Non-Executive Director

04/04/2025 - 00:13

MELBOURNE, Australia and INDIANAPOLIS, April 04, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces the appointment of Anne Whitaker as a Non-Executive [...]

Praxis Precision Medicines to Participate in Upcoming April Conferences

03/04/2025 - 23:00

BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]

Theratechnologies to Announce First Quarter 2025 Financial Results and Provide Business Update

03/04/2025 - 22:30

MONTREAL, April 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report [...]

Theratechnologies annoncera ses résultats financiers du premier trimestre de l’exercice financier de 2025 et fera une mise à jour de ses activités

03/04/2025 - 22:30

MONTRÉAL, 03 avr. 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, annonce aujourd’hui que la [...]

Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update

03/04/2025 - 22:05

-- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers -- -- Strengthened Balance Sheet through Sale of Excess Capital Equipment, Raising [...]

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

03/04/2025 - 22:05

EDEN PRAIRIE, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for [...]